Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.525 USD | -3.63% | -1.04% | -20.64% |
05-15 | Lumos Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-15 | Transcript : Lumos Pharma, Inc., Q1 2024 Earnings Call, May 15, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.64% | 21.27M | |
+42.75% | 54.04B | |
+43.57% | 41.96B | |
-1.43% | 41.92B | |
-7.59% | 28.35B | |
+11.58% | 26.35B | |
-22.04% | 19B | |
+7.72% | 13B | |
+28.53% | 12.28B | |
+25.68% | 12.19B |
- Stock Market
- Equities
- LUMO Stock
- News Lumos Pharma, Inc.
- Lumos Pharma : HC Wainwright Adjusts Lumos Pharma's Price Target to $34 From $33, Reiterates Buy Rating